Literature DB >> 28267639

Evaluation of anti-inflammatory effect of silver-coated glass beads in mice with experimentally induced colitis as a new type of treatment in inflammatory bowel disease.

Krzysztof Siczek1, Hubert Zatorski2, Anna Chmielowiec-Korzeniowska3, Radzisław Kordek4, Leszek Tymczyna3, Jakub Fichna5.   

Abstract

BACKGROUND: Recent studies point at the anti-inflammatory action of silver through induction of apoptosis of inflammatory cells via oxidative stress, promotion of wound healing as well as antimicrobial effect. Our aim was to design a new formulation based on silver and validate its anti-inflammatory activity in the mouse models of colitis.
METHODS: Silver-coated glass beads were prepared using a magnetron sputtering method and a standard magnetron sputtering gun equipped with pure silver target. Colitis was induced by the ic administration of TNBS into colon (to mimic Crohn's disease) and addition of DSS to drinking water (to imitate ulcerative colitis). Evaluation of inflammation was performed based on macroscopic and microscopic scoring, quantification of the myeloperoxidase activity and colonic microflora analysis.
RESULTS: Silver-coated glass beads administered ic alleviated intestinal inflammation in mouse models of colitis, induced by TNBS and DSS. This alleviation of colitis resulted principally from changes in the gut microflora. The anti-inflammatory action of the new formulation was associated predominantly with the presence of the silver nanolayer on the beads, and to a lesser extent the size of glass polymer units.
CONCLUSIONS: The application of the newly developed formulation employing silver-coated glass beads has the potential to be translated to clinical conditions for the efficient treatment of IBD.
Copyright © 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Crohn’s disease; Inflammatory bowel disease; Microbiota; Silver-coated glass beads; Ulcerative colitis

Mesh:

Substances:

Year:  2017        PMID: 28267639     DOI: 10.1016/j.pharep.2017.01.003

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  7 in total

Review 1.  Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives.

Authors:  Hubert Zatorski; Maciej Sałaga; Jakub Fichna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-07-29       Impact factor: 3.000

2.  Anti-Inflammatory Effects of an Extract of Polygonum hydropiper Stalks on 2,4,6-Trinitrobenzenesulphonic Acid-Induced Intestinal Inflammation in Rats by Inhibiting the NF-κB Pathway.

Authors:  Wei Zhang; Yingni Pan; Shouhe Qu; Dongmei Wang; Song Cheng; Xiaoqiu Liu
Journal:  Mediators Inflamm       Date:  2018-05-07       Impact factor: 4.711

3.  Maggot protein ameliorates dextran sulphate sodium-induced ulcerative colitis in mice.

Authors:  Rong Wang; Lei Wang; Yongzheng Luo; Daojuan Wang; Ronghui Du; Jiancheng Du; Yong Wang
Journal:  Biosci Rep       Date:  2018-11-28       Impact factor: 3.840

Review 4.  Organometallic Compounds and Metal Complexes in Current and Future Treatments of Inflammatory Bowel Disease and Colorectal Cancer-a Critical Review.

Authors:  Adrian Szczepaniak; Jakub Fichna
Journal:  Biomolecules       Date:  2019-08-22

5.  Colonic inflammation induces changes in glucose levels through modulation of incretin system.

Authors:  Hubert Zatorski; Maciej Salaga; Marta Zielińska; Anna Mokrowiecka; Damian Jacenik; Wanda Małgorzata Krajewska; Ewa Małecka-Panas; Jakub Fichna
Journal:  Pharmacol Rep       Date:  2021-09-17       Impact factor: 3.024

Review 6.  Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis.

Authors:  Inês Silva; Rui Pinto; Vanessa Mateus
Journal:  J Clin Med       Date:  2019-10-01       Impact factor: 4.241

7.  Maggot Extracts Alleviate Inflammation and Oxidative Stress in Acute Experimental Colitis via the Activation of Nrf2.

Authors:  Rong Wang; Yongzheng Luo; Yadong Lu; Daojuan Wang; Tingyu Wang; Wenyuan Pu; Yong Wang
Journal:  Oxid Med Cell Longev       Date:  2019-11-15       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.